Literature DB >> 16908558

Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences.

K Kallenberg1, W J Schulz-Schaeffer, U Jastrow, S Poser, B Meissner, H J Tschampa, I Zerr, M Knauth.   

Abstract

BACKGROUND AND
PURPOSE: MR imaging has played an increasingly important role in the diagnosis of Creutzfeldt-Jakob disease (CJD) since basal ganglia abnormalities on T2-weighted images have been described; thus, the aim of our study was to compare the value of different MR images in the diagnosis of CJD.
METHODS: One hundred fifty-seven patients with CJD underwent MR imaging examinations. Ninety-two patients were neuropathologically confirmed, and 65 were clinically classified as having CJD through the CJD Surveillance Unit (probability of 95%). There was no standardized MR imaging protocol; thus, the examinations included 143 T2-weighted, 43 proton attenuation (PD)-weighted, 84 fluid-attenuated inversion recovery (FLAIR), and 44 diffusion-weighted images (DWI). The MR images were reviewed for pathologic changes of the basal ganglia, thalamus, and cerebral cortex.
RESULTS: Cortical abnormalities were present in 70 patients (45%) and were visible in 80% (35/44) of all available DWI examinations. The basal ganglia were affected in 94 patients (60%), in particular in the caudate nucleus; the most sensitive sequences were DWI (64%) and PD-weighted (63%). A thalamic involvement was more frequently diagnosed on PD-weighted images (19%) and DWI (14%) than on FLAIR or T2-weighted images.
CONCLUSION: PD-weighted images and DWI showed better results in the diagnosis of signal intensity changes in the basal ganglia compared with T2-weighted or FLAIR images; however, in the diagnosis of cortical changes, DWI was clearly superior. Our data suggest that DWI is the most sensitive MR imaging technique in the diagnosis of CJD.

Entities:  

Mesh:

Year:  2006        PMID: 16908558      PMCID: PMC7977534     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  23 in total

1.  The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease.

Authors:  M Zeidler; R J Sellar; D A Collie; R Knight; G Stewart; M A Macleod; J W Ironside; S Cousens; A C Colchester; D M Hadley; R G Will; A F Colchester
Journal:  Lancet       Date:  2000-04-22       Impact factor: 79.321

2.  [Diffusion-weighted MRI in patients with Creutzfeldt-Jakob disease].

Authors:  S Kropp; M Finkenstaedt; I Zerr; A Schröter; S Poser
Journal:  Nervenarzt       Date:  2000-02       Impact factor: 1.214

3.  Diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  H A Kretzschmar; J W Ironside; S J DeArmond; J Tateishi
Journal:  Arch Neurol       Date:  1996-09

4.  Brain magnetic resonance diffusion abnormalities in Creutzfeldt-Jakob disease.

Authors:  M M Bahn; D K Kido; W Lin; A L Pearlman
Journal:  Arch Neurol       Date:  1997-11

Review 5.  MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data.

Authors:  H Urbach; J Klisch; H K Wolf; D Brechtelsbauer; S Gass; L Solymosi
Journal:  Neuroradiology       Date:  1998-02       Impact factor: 2.804

6.  Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease.

Authors:  A Schröter; I Zerr; K Henkel; H J Tschampa; M Finkenstaedt; S Poser
Journal:  Arch Neurol       Date:  2000-12

7.  Thalamic involvement in sporadic Creutzfeldt-Jakob disease: a diffusion-weighted MR imaging study.

Authors:  Henriette J Tschampa; Petra Mürtz; Sebastian Flacke; Sebastian Paus; Hans H Schild; Horst Urbach
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

Review 8.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

9.  Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease.

Authors:  B J Steinhoff; S Räcker; G Herrendorf; S Poser; S Grosche; I Zerr; H Kretzschmar; T Weber
Journal:  Arch Neurol       Date:  1996-02

10.  MR imaging of Creutzfeldt-Jakob disease.

Authors:  M Finkenstaedt; A Szudra; I Zerr; S Poser; J H Hise; J M Stoebner; T Weber
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

View more
  33 in total

1.  MRI abnormalities found 1 year prior to symptom onset in a case of Creutzfeldt-Jakob disease.

Authors:  Federico Verde; Nicola Ticozzi; Stefano Messina; Narghes Calcagno; Floriano Girotti; Luca Maderna; Fabio Moda; Elisa Scola; Andrea Falini; Fabrizio Tagliavini; Vincenzo Silani
Journal:  J Neurol       Date:  2016-02-12       Impact factor: 4.849

2.  Dementia and movement disorders.

Authors:  D Dormont; D J Seidenwurm
Journal:  AJNR Am J Neuroradiol       Date:  2008-01       Impact factor: 3.825

3.  Identification of the primary motor cortex: value of T2 echo-planar imaging, diffusion-weighted imaging and quantitative apparent diffusion coefficient measurement at 3 T.

Authors:  Alp Dinçer; Onur Ozyurt; Canan Erzen; M Necmettin Pamir
Journal:  Eur Radiol       Date:  2009-11-05       Impact factor: 5.315

4.  Diagnostic value of diffusion-weighted brain magnetic resonance imaging in patients with sporadic Creutzfeldt-Jakob disease: a systematic review and meta-analysis.

Authors:  Ho Young Park; Minjae Kim; Chong Hyun Suh; Sang Yeong Kim; Woo Hyun Shim; Sang Joon Kim
Journal:  Eur Radiol       Date:  2021-05-12       Impact factor: 5.315

5.  Sporadic Creutzfeldt-Jacob Disease: An 8-Year Experience from a Single Center in Turkey.

Authors:  Özlem Taşkapilioğlu; Meral Seferoğlu; Şükran Yurtoğullari; Bahattin Hakyemez; Sevda Erer; Necdet Karli; Mustafa Bakar; Ö Faruk Turan; Mehmet Zarifoğlu; Şahsine Tolunay; İbrahim Bora
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

6.  High-b-value diffusion MR imaging and basal nuclei apparent diffusion coefficient measurements in variant and sporadic Creutzfeldt-Jakob disease.

Authors:  H Hyare; J Thornton; J Stevens; S Mead; P Rudge; J Collinge; T A Yousry; H R Jäger
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-10       Impact factor: 3.825

Review 7.  Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations.

Authors:  T T Winton-Brown; A Ting; R Mocellin; M Walterfang; D Velakoulis; F Gaillard
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-07       Impact factor: 3.825

8.  Discordance of motion artifacts on magnetic resonance imaging in Creutzfeldt-Jakob disease: comparison of diffusion-weighted and conventional imaging sequences.

Authors:  Taro Shimono; Takahiro Tsuboyama; Masatomo Kuwabara; Sung-Woon Im; Yukinobu Yagyu; Izumi Imaoka; Ryuichiro Ashikaga; Makoto Hosono; Takamichi Murakami
Journal:  Radiat Med       Date:  2008-04

9.  Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study.

Authors:  Raffaele Lodi; Piero Parchi; Caterina Tonon; David Manners; Sabina Capellari; Rosaria Strammiello; Rita Rinaldi; Claudia Testa; Emil Malucelli; Barbara Mostacci; Giovanni Rizzo; Giulia Pierangeli; Pietro Cortelli; Pasquale Montagna; Bruno Barbiroli
Journal:  Brain       Date:  2009-09-15       Impact factor: 13.501

10.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  I Zerr; K Kallenberg; D M Summers; C Romero; A Taratuto; U Heinemann; M Breithaupt; D Varges; B Meissner; A Ladogana; M Schuur; S Haik; S J Collins; Gerard H Jansen; G B Stokin; J Pimentel; E Hewer; D Collie; P Smith; H Roberts; J P Brandel; C van Duijn; M Pocchiari; C Begue; P Cras; R G Will; P Sanchez-Juan
Journal:  Brain       Date:  2009-09-22       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.